Literature DB >> 12059909

Delayed toxicity of cyclophosphamide on the bladder of DBA/2 and C57BL/6 female mouse.

Elsa Anton1.   

Abstract

The present study describes the delayed development of a severe bladder pathology in a susceptible strain of mice (DBA/2) but not in a resistant strain (C57BL/6) when both were treated with a single 300 mg/kg dose of cyclophosphamide (CY). Inbred DBA/2 and C57BL/6 female mice were injected with CY, and the effect of the drug on the bladder was assessed during 100 days by light microscopy using different staining procedures, and after 30 days by conventional electron microscopy. Early CY toxicity caused a typical haemorrhagic cystitis in both strains that was completely repaired in about 7-10 days. After 30 days of CY injection ulcerous and non-ulcerous forms of chronic cystitis appeared in 86% of DBA/2 mice but only in 4% of C57BL/6 mice. Delayed cystitis was characterized by infiltration and transepithelial passage into the lumen of inflammatory cells and by frequent exfoliation of the urothelium. Mast cells appeared in the connective and muscular layers of the bladder at a much higher number in DBA/2 mice than in C57BL/6 mice or untreated controls. Electron microscopy disclosed the absence of the typical discoidal vesicles normally present in the cytoplasm of surface cells. Instead, numerous abnormal vesicles containing one or several dark granules were observed in the cytoplasm of cells from all the epithelial layers. Delayed cystitis still persisted in DBA/2 mice 100 days after treatment. These results indicate that delayed toxicity of CY in female DBA/2 mice causes a bladder pathology that is not observed in C57BL/6 mice. This pathology resembles interstitial cystitis in humans and could perhaps be used as an animal model for studies on the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12059909      PMCID: PMC2517663          DOI: 10.1046/j.1365-2613.2002.00208.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  16 in total

Review 1.  Urological complications of cyclophosphamide.

Authors:  L A Levine; J P Richie
Journal:  J Urol       Date:  1989-05       Impact factor: 7.450

2.  Cyclophosphamide and urinary bladder toxicity.

Authors:  F S PHILIPS; S S STERNBERG; A P CRONIN; P M VIDAL
Journal:  Cancer Res       Date:  1961-12       Impact factor: 12.701

Review 3.  Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis.

Authors:  A Elbadawi
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

4.  Chronic interstitial cystitis: a heterogeneous syndrome.

Authors:  M Fall; S L Johansson; F Aldenborg
Journal:  J Urol       Date:  1987-01       Impact factor: 7.450

5.  A light and electron microscopic study of the effects of a single dose of cyclophosphamide on various organs in the rat. I. The urinary bladder.

Authors:  L G Koss
Journal:  Lab Invest       Date:  1967-01       Impact factor: 5.662

6.  Lysosomes in mice mammary tumors treated with cyclophosphamide. Distribution related to course of disease.

Authors:  E Anton; D Brandes
Journal:  Cancer       Date:  1968-03       Impact factor: 6.860

7.  Cyclophosphamide cystitis--identification of acrolein as the causative agent.

Authors:  P J Cox
Journal:  Biochem Pharmacol       Date:  1979-07-01       Impact factor: 5.858

8.  Delayed toxicity of cyclophosphamide in normal mice.

Authors:  E Anton
Journal:  Br J Exp Pathol       Date:  1987-04

9.  Murine strain differences in metabolism and bladder toxicity of cyclophosphamide.

Authors:  L Fraiser; J P Kehrer
Journal:  Toxicology       Date:  1992-11-15       Impact factor: 4.221

10.  Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia.

Authors:  M LANE
Journal:  J Natl Cancer Inst       Date:  1959-12       Impact factor: 13.506

View more
  7 in total

1.  An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.

Authors:  Shizhang Ling; Xiaofei Chang; Luciana Schultz; Thomas K Lee; Alcides Chaux; Luigi Marchionni; George J Netto; David Sidransky; David M Berman
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

2.  Normalization of proliferation and tight junction formation in bladder epithelial cells from patients with interstitial cystitis/painful bladder syndrome by d-proline and d-pipecolic acid derivatives of antiproliferative factor.

Authors:  Susan Keay; Piotr Kaczmarek; Chen-Ou Zhang; Kristopher Koch; Zoltan Szekely; Joseph J Barchi; Christopher Michejda
Journal:  Chem Biol Drug Des       Date:  2011-04-27       Impact factor: 2.817

3.  Cystitis increases colorectal afferent sensitivity in the mouse.

Authors:  Pablo Rodolfo Brumovsky; Bin Feng; Linjing Xu; Carly Jane McCarthy; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

4.  Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models.

Authors:  S Cao; F A Durrani; K Tóth; Y M Rustum
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

5.  Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects.

Authors:  Marie-Laure Crouch; Gary Knowels; Rudolph Stuppard; Nolan G Ericson; Jason H Bielas; David J Marcinek; Karen L Syrjala
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 6.  Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research.

Authors:  Enrico Radaelli; Sara F Santagostino; Rani S Sellers; Cory F Brayton
Journal:  ILAR J       Date:  2018-12-31

Review 7.  NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity.

Authors:  Shanshan Wei; Wanjun Ma; Bikui Zhang; Wenqun Li
Journal:  Front Cell Dev Biol       Date:  2021-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.